Four foreign API makers have landed FDA warning letters accusing them of violations ranging from data falsification to finished product deficiencies.
Source: Drug GMP Report
Four foreign API makers have landed FDA warning letters accusing them of violations ranging from data falsification to finished product deficiencies.
Source: Drug GMP Report